Table 2.
Virusa | No. of active triazene derivatives (D–G) over 46 tested compoundsb | No. of active compounds (range of EC50, μM) | ||||
---|---|---|---|---|---|---|
Reo-1c | 3 | / | / | 1 (30) | 1 (33) | 1 (80) |
Sb-1d | 7 | / | 1 (15) | 3 (25–30) | 2 (42, 44) | 1 (51) |
HSV-1e | 6 | / | 3 (12–14) | 1 (30) | / | 2 (55, 64) |
BVDVd | 2 | / | 1 (19) | / | / | 1 (90) |
YFVd | 5 | / | 1 (20) | 2 (23, 24) | 1 (50) | 1 (80) |
RSVf | 11 | 6 (3–10) | 3 (15–20) | / | / | 2 (60, 73) |
CVB-2d | 12 | 4 (6–10) | 3 (12–14) | 2 (25, 30) | 2 (35, 50) | 1 (71) |
HIV-1, VSV and VV were unaffected by all tested compounds of structure D–G.
Compounds with EC50 > 100 μM, or higher than CC50 for the host cells are considered inactive.
Double stranded RNA virus.
Single-stranded, positive RNA virus.
DNA virus.
Single-stranded, negative RNA virus.